Lv41
800 积分 2022-09-23 加入
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
Does bevacizumab carry a hope for metastatic triple-negative breast cancer in the era of immunotherapy?
1年前
已完结
Pembrolizumab and atezolizumab in triple-negative breast cancer
1年前
已完结
Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis
1年前
已完结
Prospective and prognostic factors for hepatic metastasis of gastric carcinoma: A retrospective analysis
1年前
已关闭
Prospective and prognostic factors for hepatic metastasis of gastric carcinoma: A retrospective analysis
1年前
已关闭
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma
2年前
已完结
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial
2年前
已完结
皖公网安备34019202002308
